News

A comprehensive overview on the EU Lead Factory as a successful experiment in collaborative drug discovery was recently published in the Journal of Medicines Development Sciences. 

Just a few months after its inclusion for drug target screening, one of the first compounds synthesised within the European Lead Factory was identified as a ‘drug-like’ hit. The compounds were synthesised by the Public Chemistry Consortium, based on library proposals from academic groups and small- and medium-sized enterprises (SMEs) in Europe.

Knowledge-sharing and education are key features of the European Lead Factory. Twice a year, chemistry PostDocs from within the consortium get the opportunity to present their research at the PostDoc Learnings and Achievements meeting.

CELLIPSE was awarded an exclusive High Throughput Screening research program to screen the EU Lead Factory’s (ELF) joint compound library on an undisclosed innovative therapeutic target, by the Selection Committee on January 19 2015.